We also explored the antidepressant mechanism of NAc-DBS and found that it exerted antidepressant effects and cognitive improvement in a CUMS-induced depression-like mouse model through the activation of BDNF/AKT/mTOR signaling pathway. This evidence concerns the gene AKT1 and depressive symptom measurement.